Your email has been successfully added to our mailing list.

×
-0.00232558139534893 -0.00232558139534893 -0.00232558139534893 -0.00232558139534893 -0.00232558139534893 -0.00232558139534893 0 0
Stock impact report

BioCardia Welcomes Cardiovascular Device Veteran Mark Schwartz as Vice President of Clinical Affairs

BioCardia, Inc. (BCDA)  More Company Research Source: Business Wire
PDF SAN CARLOS, Calif.--(BUSINESS WIRE)-- BioCardia® [OTC: BCDA] today announced that Mark Schwartz, a 25-year veteran of cardiovascular device development, has joined the company as Vice President of Clinical Affairs, effective November 1. Schwartz brings extensive leadership experience in the design and execution of clinical studies for medical devices in the heart leading to regulatory approvals for such industry leaders as Boston Scientific, The Sorin Group and Guidant, among others. Schwartz comes to BioCardia from EBR Systems, where he served as Vice President of Clinical and Regulatory Affairs for the developer of cardiac resynchronization therapy. Previously, he served as Senior Director of Clinical Affairs for The Sorin Group, leading the U.S. clinical program for the company’s cardiac rhythm management and heart valve programs. There, he had oversight for IDE, research and post-market studies [Read more]
Impact snapshot Event time: BCDA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
BCDA alerts
from News Quantified
Opt-in for
BCDA alerts

from News Quantified
Opt-in for
BCDA alerts

from News Quantified